Provider: Nature Publishing Group Content: application/x-research-info-systems TY - JOUR AU - Folkman, J. TI - Addressing tumor blood vessels JO - Nature Biotechnol. PY - 1997/// VL - 15 SP - EP - 510 M3 - 10.1038/nbt0697-510 N1 - 10.1038/nbt0697-510 UR - http://dx.doi.org/10.1038/nbt0697-510 ER - TY - JOUR AU - Folkman, J. TI - Angiogenesis and angiogenesis inhibition: An overview JO - EXS PY - 1997/// VL - 79 SP - 1 EP - 8 ER - TY - JOUR AU - Folkman, J. TI - Antiangiogenic gene therapy JO - Proc. Natl. Acad. Sci. USA PY - 1998/// VL - 95 SP - 9064 EP - 9066 M3 - 10.1073/pnas.95.16.9064 N1 - 10.1073/pnas.95.16.9064 UR - http://dx.doi.org/10.1073/pnas.95.16.9064 ER - TY - JOUR AU - O'Reilly, M.S. AU - Holmgren, L. AU - Chen, C. AU - Folkman, J. TI - Angiostatin induces and sustains dormancy of human primary tumors in mice JO - Nature Med. PY - 1996/// VL - 2 SP - 689 EP - 692 M3 - 10.1038/nm0696-689 N1 - 10.1038/nm0696-689 UR - http://dx.doi.org/10.1038/nm0696-689 ER - TY - JOUR AU - O'Reilly, M.S. TI - Endostatin: An endogenous inhibitor of angiogenesis and tumor growth JO - Cell PY - 1997/// VL - 88 SP - 277 EP - 285 M3 - 10.1016/S0092-8674(00)81848-6 N1 - 10.1016/S0092-8674(00)81848-6 UR - http://dx.doi.org/10.1016/S0092-8674(00)81848-6 ER - TY - JOUR AU - Augustin, H.G. TI - Antiangiogenic tumor therapy: Will it work? JO - Trends Pharmacol. Sci. PY - 1998/// VL - 19 SP - 216 EP - 222 M3 - 10.1016/S0165-6147(98)01211-5 N1 - 10.1016/S0165-6147(98)01211-5 UR - http://dx.doi.org/10.1016/S0165-6147(98)01211-5 ER - TY - JOUR AU - Eberhard, A. TI - Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies JO - Cancer Res. PY - 2000/// VL - 60 SP - 1388 EP - 1393 ER - TY - JOUR AU - Folkman, J. TI - Tumor angiogenesis and tissue factor JO - Nature Med. PY - 1996/// VL - 2 SP - 167 EP - 168 M3 - 10.1038/nm0296-167 N1 - 10.1038/nm0296-167 UR - http://dx.doi.org/10.1038/nm0296-167 ER - TY - JOUR AU - Goede, V. TI - Prognostic value of angiogenesis in mammary tumors JO - Anticancer Res. PY - 1998/// VL - 18 SP - 2199 EP - 2202 ER - TY - JOUR AU - Folkman, J. TI - Can mosaic tumor vessels facilitate molecular diagnosis of cancer? JO - Proc. Natl. Acad. Sci. USA PY - 2001/// VL - 98 SP - 398 EP - 400 M3 - 10.1073/pnas.98.2.398 N1 - 10.1073/pnas.98.2.398 UR - http://dx.doi.org/10.1073/pnas.98.2.398 ER - TY - JOUR AU - Heidenreich, R. AU - Kappel, A. AU - Breier, G. TI - Tumor endothelium-specific transgene expression directed by vascular endothelial growth factor receptor-2 (FLK-1) promoter/enhancer sequences JO - Cancer Res. PY - 2000/// VL - 60 SP - 6142 EP - 6147 ER - TY - JOUR AU - Hicklin, D.J. AU - Marincola, F.M. AU - Ferrone, S. TI - HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story JO - Mol. Med. Today PY - 1999/// VL - 5 SP - 178 EP - 186 M3 - 10.1016/S1357-4310(99)01451-3 N1 - 10.1016/S1357-4310(99)01451-3 UR - http://dx.doi.org/10.1016/S1357-4310(99)01451-3 ER - TY - JOUR AU - Ruiter, D.J. AU - Mattijssen, V. AU - Broecker, E.B. AU - Ferrone, S. TI - MHC antigens in human melanomas JO - Semin. Cancer Biol. PY - 1991/// VL - 2 SP - 35 EP - 45 ER - TY - JOUR AU - Cheng, W.F. TI - Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen JO - J. Clin. Invest. PY - 2001/// VL - 108 SP - 669 EP - 678 M3 - 10.1172/JCI200112346 N1 - 10.1172/JCI200112346 UR - http://dx.doi.org/10.1172/JCI200112346 ER - TY - JOUR AU - Wei, Y.Q. TI - Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine JO - Nature Med. PY - 2000/// VL - 6 SP - 1160 EP - 1166 M3 - 10.1038/80506 N1 - 10.1038/80506 UR - http://dx.doi.org/10.1038/80506 ER - TY - JOUR AU - Kisker, O. TI - Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model JO - Cancer Res. PY - 2001/// VL - 61 SP - 7669 EP - 7674 ER - TY - JOUR AU - Cross, M.J. AU - Claesson-Welsh, L. TI - FGF and VEGF function in angiogenesis: signaling pathways, biological responses and therapeutic inhibition JO - Trends Pharmacol. Sci. PY - 2001/// VL - 22 SP - 201 EP - 207 M3 - 10.1016/S0165-6147(00)01676-X N1 - 10.1016/S0165-6147(00)01676-X UR - http://dx.doi.org/10.1016/S0165-6147(00)01676-X ER - TY - JOUR AU - Dias, S. TI - Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration JO - J. Clin. Invest. PY - 2000/// VL - 106 SP - 511 EP - 521 ER - TY - JOUR AU - Drake, C.J. AU - LaRue, A. AU - Ferrara, N. AU - Little, C.D. TI - VEGF regulates cell behavior during vasculogenesis JO - Dev. Biol. PY - 2000/// VL - 224 SP - 178 EP - 188 M3 - 10.1006/dbio.2000.9744 N1 - 10.1006/dbio.2000.9744 UR - http://dx.doi.org/10.1006/dbio.2000.9744 ER - TY - JOUR AU - Ferrara, N. TI - VEGF: An update on biological and therapeutic aspects JO - Curr. Opin. Biotechnol. PY - 2000/// VL - 11 SP - 617 EP - 624 M3 - 10.1016/S0958-1669(00)00153-1 N1 - 10.1016/S0958-1669(00)00153-1 UR - http://dx.doi.org/10.1016/S0958-1669(00)00153-1 ER - TY - JOUR AU - Folkman, J. AU - D'Amore, P.A. TI - Blood vessel formation: what is its molecular basis? JO - Cell PY - 1996/// VL - 87 SP - 1153 EP - 1155 M3 - 10.1016/S0092-8674(00)81810-3 N1 - 10.1016/S0092-8674(00)81810-3 UR - http://dx.doi.org/10.1016/S0092-8674(00)81810-3 ER - TY - JOUR AU - McMahon, G. TI - VEGF receptor signaling in tumor angiogenesis JO - Oncologist PY - 2000/// VL - 5 SP - 3 EP - 10 M3 - 10.1159/000013861 N1 - 10.1159/000013861 UR - http://dx.doi.org/10.1159/000013861 ER - TY - JOUR AU - Ortega, N. AU - Hutchings, H. AU - Plouet, J. TI - Signal relays in the VEGF system JO - Front Biosci. PY - 1999/// VL - 4 SP - D141 EP - D152 ER - TY - JOUR AU - Strawn, L.M. TI - FLK-1 as a target for tumor growth inhibition JO - Cancer Res. PY - 1996/// VL - 56 SP - 3540 EP - 3545 ER - TY - JOUR AU - Taraboletti, G. AU - Margosio, B. TI - Antiangiogenic and antivascular therapy for cancer JO - Curr. Opin. Pharmacol. PY - 2001/// VL - 1 SP - 378 EP - 384 M3 - 10.1016/S1471-4892(01)00065-0 N1 - 10.1016/S1471-4892(01)00065-0 UR - http://dx.doi.org/10.1016/S1471-4892(01)00065-0 ER - TY - JOUR AU - Ochsenbein, A.F. TI - Roles of tumor localization, second signals and cross priming in cytotoxic T-cell induction JO - Nature PY - 2001/// VL - 411 SP - 1058 EP - 1064 M3 - 10.1038/35082583 N1 - 10.1038/35082583 UR - http://dx.doi.org/10.1038/35082583 ER - TY - JOUR AU - Hata, Y. AU - Rook, S.L. AU - Aiello, L.P. TI - Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway JO - Diabetes PY - 1999/// VL - 48 SP - 1145 EP - 1155 ER - TY - JOUR AU - St Croix, B. TI - Genes expressed in human tumor endothelium JO - Science PY - 2000/// VL - 289 SP - 1197 EP - 1202 M3 - 10.1126/science.289.5482.1197 N1 - 10.1126/science.289.5482.1197 UR - http://dx.doi.org/10.1126/science.289.5482.1197 ER - TY - JOUR AU - Niethammer, A.G. TI - An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice JO - Vaccine PY - 2001/// VL - 20 SP - 421 EP - 429 M3 - 10.1016/S0264-410X(01)00362-0 N1 - 10.1016/S0264-410X(01)00362-0 UR - http://dx.doi.org/10.1016/S0264-410X(01)00362-0 ER - TY - JOUR AU - Niethammer, A.G. TI - Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma JO - Cancer Res. PY - 2001/// VL - 61 SP - 6178 EP - 6184 ER - TY - JOUR AU - Darji, A. TI - Oral somatic transgene vaccination using attenuated S. typhimurium JO - Cell PY - 1997/// VL - 91 SP - 765 EP - 775 M3 - 10.1016/S0092-8674(00)80465-1 N1 - 10.1016/S0092-8674(00)80465-1 UR - http://dx.doi.org/10.1016/S0092-8674(00)80465-1 ER - TY - JOUR AU - Lode, H.N. TI - Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma JO - Proc. Natl. Acad. Sci. USA PY - 1998/// VL - 95 SP - 2475 EP - 2480 M3 - 10.1073/pnas.95.5.2475 N1 - 10.1073/pnas.95.5.2475 UR - http://dx.doi.org/10.1073/pnas.95.5.2475 ER - TY - JOUR AU - Schrama, D. TI - Targeting of lymphotoxin-[alpha] to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue JO - Immunity PY - 2001/// VL - 14 SP - 111 EP - 121 ER - TY - JOUR AU - Kaesler, S. AU - Regenbogen, J. AU - Durka, S. AU - Goppelt, A. AU - Werner, S. TI - The healing skin wound: A novel site of action of the chemokine c10 JO - Cytokine PY - 2002/// VL - 17 SP - 157 EP - 163 M3 - 10.1006/cyto.2001.0981 N1 - 10.1006/cyto.2001.0981 UR - http://dx.doi.org/10.1006/cyto.2001.0981 ER - TY - JOUR AU - Werner, S. TI - Large induction of keratinocyte growth factor expression in the dermis during wound healing JO - Proc. Natl. Acad. Sci. USA PY - 1992/// VL - 89 SP - 6896 EP - 6900 ER - TY - JOUR AU - Barlow, C. TI - Atm-deficient mice: A paradigm of ataxia telangiectasia JO - Cell PY - 1996/// VL - 86 SP - 159 EP - 171 M3 - 10.1016/S0092-8674(00)80086-0 N1 - 10.1016/S0092-8674(00)80086-0 UR - http://dx.doi.org/10.1016/S0092-8674(00)80086-0 ER - TY - JOUR AU - Paylor, R. TI - Alpha7 nicotinic receptor subunits are not necessary for hippocampal- dependent learning or sensorimotor gating: A behavioral characterization of Acra7-deficient mice JO - Learn. Mem. PY - 1998/// VL - 5 SP - 302 EP - 316 ER -